{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-000699","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.761712+00:00","generated_at":"2026-06-20T17:38:10.416299+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Puma Biotechnology files 8-K for investor presentations; no material new info disclosed","bullets":["Chairman, President & CEO Alan Auerbach to present at investor conferences starting Jan 9, 2023.","Presentation materials furnished as Exhibit 99.1; no specific financial or operational updates in filing text.","No earnings, guidance, or corporate events announced in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-000699","json":"https://secwatch.observer/filing/0001437749-23-000699.json","markdown":"https://secwatch.observer/filing/0001437749-23-000699.md","text":"https://secwatch.observer/filing/0001437749-23-000699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923000699/0001437749-23-000699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923000699/pbyi20230105_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:38:10.416299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}